79 related articles for article (PubMed ID: 9179280)
21. Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response.
Dubey C; Croft M; Swain SL
J Immunol; 1995 Jul; 155(1):45-57. PubMed ID: 7541426
[TBL] [Abstract][Full Text] [Related]
22. Admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunity.
Hodge JW; McLaughlin JP; Abrams SI; Shupert WL; Schlom J; Kantor JA
Cancer Res; 1995 Aug; 55(16):3598-603. PubMed ID: 7543017
[TBL] [Abstract][Full Text] [Related]
23. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR.
Giese T; Allison JP; Davidson WF
J Immunol; 1993 Jul; 151(2):597-609. PubMed ID: 7687618
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity of biliary epithelium: investigation of antigen presentation to CD4+ T cells.
Leon MP; Bassendine MF; Wilson JL; Ali S; Thick M; Kirby JA
Hepatology; 1996 Sep; 24(3):561-7. PubMed ID: 8781325
[TBL] [Abstract][Full Text] [Related]
25. Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen.
Cardoso AA; Schultze JL; Boussiotis VA; Freeman GJ; Seamon MJ; Laszlo S; Billet A; Sallan SE; Gribben JG; Nadler LM
Blood; 1996 Jul; 88(1):41-8. PubMed ID: 8704200
[TBL] [Abstract][Full Text] [Related]
26. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation.
Gimmi CD; Freeman GJ; Gribben JG; Gray G; Nadler LM
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6586-90. PubMed ID: 7688125
[TBL] [Abstract][Full Text] [Related]
27. Costimulatory molecules as immunotherapeutic targets in systemic lupus erythematosus.
Foell J; Mittler RS
Springer Semin Immunopathol; 2006 Oct; 28(2):153-62. PubMed ID: 16951932
[TBL] [Abstract][Full Text] [Related]
28. Alternate costimulatory molecules in T cell activation: differential mechanisms for directing the immune response.
Kohlmeier JE; Benedict SH
Histol Histopathol; 2003 Oct; 18(4):1195-204. PubMed ID: 12973688
[TBL] [Abstract][Full Text] [Related]
29. The immune response: the afferent arm.
Czitrom AA
Clin Orthop Relat Res; 1996 May; (326):11-24. PubMed ID: 8620631
[TBL] [Abstract][Full Text] [Related]
30. Costimulatory signals for human T-cell activation induce nuclear translocation of pp19/cofilin.
Samstag Y; Eckerskorn C; Wesselborg S; Henning S; Wallich R; Meuer SC
Proc Natl Acad Sci U S A; 1994 May; 91(10):4494-8. PubMed ID: 8183936
[TBL] [Abstract][Full Text] [Related]
31. [The role of costimulatory molecules in immune responses in acute leukemia].
Cielińska S; Urbaniak-Kujda D; Kapelko-Słowik K; Kuliczkowski K
Pol Arch Med Wewn; 2001 May; 105(5):417-21. PubMed ID: 11865595
[No Abstract] [Full Text] [Related]
32. Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity.
Schultze JL; Cardoso AA; Freeman GJ; Seamon MJ; Daley J; Pinkus GS; Gribben JG; Nadler LM
Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8200-4. PubMed ID: 7545296
[TBL] [Abstract][Full Text] [Related]
33. [Molecular pathways of T lymphocyte activation].
Bernard G; Bernard A
Presse Med; 1999 Dec 18-25; 28(40):2251-6. PubMed ID: 10636021
[TBL] [Abstract][Full Text] [Related]
34. New biologic immunosuppressive agents in transplantation.
Gratiot-Deans J; Turka LA
Curr Opin Nephrol Hypertens; 1994 Nov; 3(6):596-601. PubMed ID: 7881982
[TBL] [Abstract][Full Text] [Related]
35. Why do B cell lymphoma fail to elicit clinically sufficient T cell immune responses?
Schultze JL
Leuk Lymphoma; 1999 Jan; 32(3-4):223-36. PubMed ID: 10037020
[TBL] [Abstract][Full Text] [Related]
36. Immunologic nonresponsiveness to tumors.
Antonia SJ; Extermann M; Flavell RA
Crit Rev Oncog; 1998; 9(1):35-41. PubMed ID: 9754446
[TBL] [Abstract][Full Text] [Related]
37. The impact of gene therapy on T cell function in cancer.
Zier KS; Gansbacher B
Hum Gene Ther; 1995 Oct; 6(10):1259-64. PubMed ID: 8590729
[TBL] [Abstract][Full Text] [Related]
38. Transcription Activator-Like Nucleases Enable Allogeneic Chimeric Antigen Receptor-T Cell Therapy in Humans.
Flotte TR
Hum Gene Ther; 2015 Nov; 26(11):iv. PubMed ID: 26565678
[No Abstract] [Full Text] [Related]
39. [Mechanisms of immunosuppression in leukemia].
Luczyński W; Krawczuk-Rybak M
Postepy Hig Med Dosw (Online); 2005; 59():28-33. PubMed ID: 15761383
[TBL] [Abstract][Full Text] [Related]
40. Altered T cell signalling in ageing.
Pawelec G; Hirokawa K; Fülöp T
Mech Ageing Dev; 2001 Sep; 122(14):1613-37. PubMed ID: 11511400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
